title: Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin.
abstract: METHODS
  Naturally-occurring chemopreventive agent phenethyl isothiocyanate (PEITC), derived primarily from watercress, has been shown to inhibit cell growth and induce apoptosis in cancer cells. In this study, we examined the potential of PEITC in enhancing cisplatin-induced apoptosis in cervical cancer cells and its mechanisms.
  
  
  RESULTS
  HeLa cells were exposed to PEITC, cisplatin or both. Pretreatment of cells with PEITC strongly enhanced cisplatin-induced cytotoxicity. PEITC activated the mitogen-activated protein kinases, including c-Jun N-terminal kinase (JNK), extracellular signal-related kinase (ERK), and p38. Caspase-3 activity assay demonstrated that the synergistic induction of apoptosis was significantly attenuated by MEK1/2 inhibitor U0126, but not by JNK or p38 inhibitor, suggesting that ERK activation is responsible for the synergistic effect. We found that NF-κB signaling pathway is not involved in the synergistic effect. Sulforaphane and benzyl isothiocyanate, two other members of the isothiocyanate family, also sensitize HeLa cells to apoptosis induced by cisplatin. Furthermore, we found that the synergistic effect was also observed in cervical cancer C33A and breast cancer MCF-7 cells but not in normal mammary epithelial MCF-10A cells. Finally, we demonstrated that Noxa induction was associated with apoptosis induced by PEITC plus cisplatin.
  
  
  CONCLUSIONS
  Taken together, this study shows that PEITC can sensitize cancer cells to apoptosis induced by cisplatin and this effect is mediated through ERK activation, suggesting the potential of PEITC to be used as an adjuvant with cisplatin in combination therapeutic treatments.
authors: Lombardi Comprehensive Cancer Center, Georgetown University, 3800Reservoir Road NW, Washington, DC 20057, USA. xw26@georgetown.edu
authors: Xiantao
authors: X
authors: Wang
authors: Sudha
authors: S
authors: Govind
authors: Shyama P
authors: SP
authors: Sajankila
authors: Lixin
authors: L
authors: Mi
authors: Rabindra
authors: R
authors: Roy
authors: Fung-Lung
authors: FL
authors: Chung
references: Mutat Res. 2006 Oct 10;601(1-2):92-101
references: 16843502
references: Clin Cancer Res. 2005 Apr 1;11(7):2670-9
references: 15814648
references: Pharm Res. 2004 Apr;21(4):661-70
references: 15139523
references: Clin Cancer Res. 1999 May;5(5):1007-14
references: 10353733
references: Pharm Res. 2010 Apr;27(4):722-31
references: 20182772
references: Cancer Res. 2006 Sep 15;66(18):9260-9
references: 16982771
references: Nature. 2001 Mar 1;410(6824):37-40
references: 11242034
references: Cancer Res. 2002 Jul 1;62(13):3615-9
references: 12097262
references: Gynecol Oncol. 2006 Oct;103(1):261-70
references: 16624391
references: Anal Biochem. 2001 Apr 15;291(2):279-89
references: 11401302
references: Curr Drug Metab. 2002 Jun;3(3):233-55
references: 12083319
references: Curr Opin Cell Biol. 2005 Dec;17(6):617-25
references: 16243507
references: Oncogene. 2003 Oct 20;22(47):7265-79
references: 14576837
references: Oncogene. 2005 Jun 30;24(28):4486-95
references: 15856023
references: Nat Rev Cancer. 2002 Jun;2(6):420-30
references: 12189384
references: Carcinogenesis. 2006 Mar;27(3):437-45
references: 16272172
references: J Biol Chem. 2001 Aug 24;276(34):32008-15
references: 11410599
references: Mol Cancer Ther. 2005 Aug;4(8):1250-9
references: 16093441
references: Carcinogenesis. 2007 May;28(5):1058-66
references: 17183064
references: Carcinogenesis. 2006 Sep;27(9):1768-77
references: 16571651
references: Mol Carcinog. 2005 Jul;43(3):130-40
references: 15880419
references: Carcinogenesis. 2003 Aug;24(8):1361-7
references: 12819185
references: Cancer Res. 2006 Feb 1;66(3):1740-50
references: 16452234
references: Carcinogenesis. 2004 May;25(5):765-72
references: 14729592
references: Nat Rev Cancer. 2005 Apr;5(4):297-309
references: 15803156
references: J Biol Chem. 1998 Jan 16;273(3):1769-75
references: 9430725
references: J Biol Chem. 2000 Dec 15;275(50):39435-43
references: 10993883
references: Neurotoxicology. 2004 Dec;25(6):915-24
references: 15474610
references: Curr Opin Oncol. 1990 Dec;2(6):1109-14
references: 2099841
references: Cancer Res. 2002 Jan 1;62(1):2-7
references: 11782348
references: Oncol Rep. 2004 Feb;11(2):493-9
references: 14719089
references: Chem Res Toxicol. 2010 Aug 16;23(8):1307-9
references: 20707406
references: J Biol Chem. 1999 Oct 29;274(44):31648-54
references: 10531373
references: J Biol Chem. 2009 Jun 19;284(25):17039-17051
references: 19339240
references: Nature. 2006 May 25;441(7092):431-6
references: 16724054
references: Mutat Res. 2004 Nov 2;555(1-2):191-202
references: 15476860
references: Mol Ther. 2011 Jan;19(1):188-95
references: 20940707
references: Oncogene. 1997 Dec 11;15(24):2991-7
references: 9416843
references: Cancer Res. 2006 Apr 1;66(7):3347-50
references: 16585150
references: Carcinogenesis. 2006 Nov;27(11):2223-34
references: 16774948
references: Cancer Res. 2005 Sep 15;65(18):8548-57
references: 16166336